.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer in 2014 for a monstrous $4...
.On the heels of a stage 3 win that fell short to blow away real estate investors, Ironwood Pharmace...
.Don't stop Monte Rosa Rehabs currently. The Boston-based biotech is actually enjoying after signing...
.Welcome to recently's Chutes & Ladders, our roundup of substantial management hirings, shootings...
.Commemorating his business's upsized going public (IPO), Septerna CEO Jeffrey Finer called the open...
.AbbVie has returned to the resource of its antipsychotic giant Vraylar in search of an additional s...
.GenSight Biologics is actually weeks off of lacking funds. Once again. The biotech merely possesses...
.Monopar Therapies is actually recovering a medicine from the scrap heap of AstraZeneca's rare healt...
.Along with brand-new data out on Arcus Biosciences' experimental HIF-2a prevention, one group of ex...
.After developing a genetics therapy partnership along with Dyno Rehabs in 2020, Roche is back for m...